| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec21239ee17b84496b9371f7d49c2ef8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bba710e7aaa56d8ab15a910fcd3dc5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1447d10c00d46fd3863869d42e33df44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed8b5c72be18a88c9a5a58cd2aec7698 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-978 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92aa3a723469fce942bf2e0a4e17ebba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8078a60eaefe951ac99997a5958379c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217468741e21617721b15ac68461339c |
| publicationDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011143553-A1 |
| titleOfInvention |
Compositions and methods for targeting a3g:rna complexes |
| abstract |
The present invention provides an assay for screening any agent that modulates the ability of A3G to bind with RNA. The invention provides an agent identified by high throughput screening methods and methods of treatment using the identified agent as a means of inhibiting HIV infection and reducing the emergence of viral drug-resistance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017075056-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10941158-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108368125-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10941157-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014186423-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098055-B2 |
| priorityDate |
2010-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |